Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGN ...

Cell replacement therapy offers new hope for millions of people affected by retinal degenerations (RDs)—a group of blinding ...

Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the elderly population globally. Despite its prevalence, the exact molecular ...

Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the elderly population globally. Despite its prevalence, the exact molecular ...

The research has implications for understanding how the brain compensates for vision loss caused by diseases such as glaucoma and age-related macular degeneration. “By measuring how these neurons ...

Rapid Response From Clinical Trials at the Summit: Transforming Retinal Disease Care With New Data This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Eylea is prescribed to prevent vision loss from conditions like wet age-related macular degeneration and diabetic macular edema by targeting and blocking a protein called vascular endothelial ...

Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGNAnnounced capped royalty purchase agreement with Sobi under which Apel ...

Learn about uses, side effects, dosage, and more for Izervay, a prescription drug used to treat geographic atrophy due to age-related macular degeneration.

News Weird News Archaeology Massive Biblical battle unearthed as previously unexplored 'Area X' begins to give up its secrets Previously unexplored 'Area X' unearths new evidence that Josiah, the ...

Geographic atrophy is an advanced form of dry age-related macular degeneration (AMD), according to the American Macular Degeneration Foundation.